207_Combined course Presentations
Endpoints
• Primary: Safety
• Secondary:
Humoral immunogenicity Cell-mediated immunogenicity Impact of escalating doses of HER2
G. Curigliano et al. 2016
Made with FlippingBook
Endpoints
• Primary: Safety
• Secondary:
Humoral immunogenicity Cell-mediated immunogenicity Impact of escalating doses of HER2
G. Curigliano et al. 2016
Made with FlippingBook